Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]

B. G.M. Durie; S. V. Rajkumar

doi:10.1038/sj.leu.2404574

Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]

B. G.M. Durie, S. V. Rajkumar

Hematology

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Number of pages	1
Journal	Leukemia
Volume	21
Issue number	4
DOIs	https://doi.org/10.1038/sj.leu.2404574
State	Published - Apr 2007

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/sj.leu.2404574

Cite this

@article{606b7c7381b246f8bbeffb506ebfee35,

title = "Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]",

author = "Durie, {B. G.M.} and Rajkumar, {S. V.}",

year = "2007",

month = apr,

doi = "10.1038/sj.leu.2404574",

language = "English (US)",

volume = "21",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma

T2 - A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]

AU - Durie, B. G.M.

AU - Rajkumar, S. V.

PY - 2007/4

Y1 - 2007/4

UR - http://www.scopus.com/inward/record.url?scp=33947434523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947434523&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2404574

DO - 10.1038/sj.leu.2404574

M3 - Letter

AN - SCOPUS:33947434523

SN - 0887-6924

VL - 21

JO - Leukemia

JF - Leukemia

IS - 4

ER -

Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this